IL1B and cryopyrin-associated periodic syndrome: Notably, either IL-17 serum concentrations or the increased number of IL-17 producing cells observed in CAPS patients were clearly down-modulated by anti IL-1β treatment, suggesting a possible IL-1 dependency of the TH17 skewed phenotype observed in CAPS patients.